| Literature DB >> 32443913 |
Emmanouil Kontaxakis1, Emmanouil Trantas1, Filippos Ververidis1.
Abstract
In recent years, significant efforts to produce healthier wines has led to the replacement or reduction of the addition of sulfites, using alternative substances or techniques. Resveratrol and related biophenols seem to be of great interest, since beyond their protective nature and contrary to sulfites they can positively affect consumer health. These bioactive phytochemicals are naturally produced in grapes as evolutionary acquired mechanisms against pathogens and UV irradiation. However, despite the efforts made so far attempting to develop economic and industrially adopted isolation techniques, available quantities of these biophenols for commercial use are still quite limited. Therefore, such molecules are still not able to meet the needs of industrial use due to their prohibitive marketable cost. In this review we summarize the efforts that have been made to biosynthesize these molecules through alternative, innovative ways. Increasing interest in modern biotechnological approaches has shed light on the exploitation of metabolically engineered microbial factories, instead of plants, to produce molecules of industrial interest. Such approaches, also reviewed here, are expected to lower the cost and appear promising to produce enough surplus to attract further oenological experimentation upon yielding functional wines. This development is expected to attract further industrial attention, continuing the race to partially or totally replace the external addition of sulfites. We also review important physicochemical properties of resveratrol in relation to enriching wines.Entities:
Keywords: antioxidant; functional wine; health effects; metabolic engineering; resveratrol; sulfites; sulfur dioxide; wine making
Mesh:
Substances:
Year: 2020 PMID: 32443913 PMCID: PMC7288175 DOI: 10.3390/molecules25102378
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Upper limits for total sulfur dioxide (SO2) in wines in major winemaking regions worldwide.
| Region | Limit | Regulatory |
|---|---|---|
| Australia | 250 mg/L for wines containing <35 g/L sugars | Australia New Zealand Food Standards Code–Standard 4.5.1: Clause 5(5)(a) |
| Canada | 70 mg/L for all wines (free SO2) | Can. Food and Drug Regulations (C.R.C., c. 870), B.02.100 |
| European Union | 150 mg/L for red wines (containing ≤5 g/L of sugar content) | Regulation (EU) 2019/934 |
| India | 450 mg/L for all wines | The Prevention of Food Adulteration Act & Rules |
| Japan | 350 mg/Kg for all wines | Japan′s Specifications and Standards for Food Additives |
| New Zealand | 250 mg/Kg for wines containing <35 g/L sugars | Australia New Zealand Food Standards Code–Standard 4.5.1: Clause 5(5)(a) |
| South Africa | 160 mg/L for white wines (containing <5 g/L of sugars) | Liquor Products Act 60 Regulation 32, Table 8, Note 2 |
| United States of America | 350 mg/L for all wines (total SO2) | Code of Federal Regulations, 27 CFR § 4.22 |
| World–International Organisation of Vine and Wine (OIV) | 150 mg/L for red wines (containing ≤4 g/L of reducing substances) | International Code of Oenological Practices (Issue 2019) |
trans-Resveratrol content of white, rosé, and red wines, from the major winemaking countries worldwide.
| Country | Wine Color | Sample Number | Reference | ||
|---|---|---|---|---|---|
| Range | Mean | ||||
| Australia | Red | 0.100–0.950 | 0.440 | 5 | [ |
| Red | 1.461–1.548 | 1.504 | 2 | [ | |
| Red | 2.371 | 35 | [ | ||
| Brazil | Red | 0.820–5.750 | 2.570 | 36 | [ |
| California | Red | 0.226–2.319 | 0.864 | 8 | [ |
| Red | 1.685 | 72 | [ | ||
| France | Red | 1.735–2.901 | 1.966 | 4 | [ |
| Red | 2.085 | 48 | [ | ||
| Greece | Red | 0.550–2.534 | 1.105 | 29 | [ |
| Red | 0.325–1.569 | 0.873 | 15 | [ | |
| White | 0.026–0.142 | 0.043 | 15 | [ | |
| Red | 0.352–1.991 | 0.895 | 13 | [ | |
| White | 0.005–0.571 | 0.229 | 18 | [ | |
| Hungary | Red | 0.100–14.300 | 2.380 | 68 | [ |
| White | 0.200–0.780 | 0.563 | 3 | [ | |
| Italy | Red | 0.657–1.155 | 0.984 | 3 | [ |
| Spain | Red | 0.320–4.440 | 1.471 | 74 | [ |
| Rosé | 0.120–2.800 | 0.669 | 24 | [ | |
| Red | 0.600–8.000 | 2.485 | 18 | [ | |
| Red | <0.012–0.472 | 0.179 | 14 | [ | |
| White | <0.012–0.062 | 0.024 | 8 | [ | |
| Turkey | Red | 0.176–4.403 | 1.203 | 7 | [ |
| White | 0.116–1.243 | 0.891 | 4 | [ | |
Minimum inhibitory concentration (MIC) of resveratrol [mg/L] on wine-related microorganisms.
| Species | MIC (mg/L) | Reference | |
|---|---|---|---|
| Yeasts |
| 250 | [ |
|
| 256 | [ | |
|
| 256 | [ | |
|
| 250 | [ | |
|
| 250 | [ | |
| 256 | [ | ||
|
| 250 | [ | |
|
| 250–500 | [ | |
|
| 256 | [ | |
|
| 512 | [ | |
| Acetic Acid Bacteria |
| 250 | [ |
| 256 | [ | ||
|
| 256 | [ | |
|
| 256 | [ | |
|
| >1000 | [ | |
| Lactic Acid Bacteria |
| 250 | [ |
|
| 250 | [ | |
|
| 250 | [ | |
| 307–698 | [ | ||
|
| 250 | [ | |
|
| 715 | [ |
Figure 1Visual representation of resveratrol sources to create enriched types of wine.
Figure 2Representation of the biosynthetic pathway that transforms phenylalanine or tyrosine coming from primary metabolism into selected stilbenoids.
Recorded reports of resveratrol production utilizing precursor molecules derived from primary metabolism (e.g., phenylalanine or tyrosine) or added. NA, not added; GO, gene overexpression; F, utilization of fussed enzymes; OPT, utilization of codon-optimized genes; TRA, utilization of a transporter, GOCI, gene expression from chromosomal integration; BIOR, fed-batch fermentation in controlled bioreactor; OPM, overexpression of genes of the primary metabolism; IPCO, increase the pool of implicated co-factors; MOC, utilization of a monoculture approach; COC, utilization of a co-culture approach; KOG, knock-out of specific genes of the primary metabolism; CER, addition of cerulenin; NE, not estimated; NA, not applied.
| End Product | Precursor Molecule (Alternative Source) | Number of Genes | Target Genes and Sources | Strategy | Host Organism | Production Level (mg/L) | Reference |
|---|---|---|---|---|---|---|---|
| Resveratrol | NA | 3 | MOC | Human HEK293 cells | 0.0283 | [ | |
| Resveratrol | Phenylalanine | 5 | MOC |
| 0.29 | [ | |
| Resveratrol | Galactose | 3 | MOC |
| 1.06 | [ | |
| Resveratrol | Tyrosine | 3 | MOC |
| 1.4 | [ | |
| Resveratrol | Galactose (Tyrosine) | 4 | MOC |
| 4.3 | [ | |
| Resveratrol | Glycerol | 5 | COC |
| 22.6 | [ | |
| Resveratrol | Glucose | 6 | MOC |
| 415.65 | [ | |
| Resveratrol | Glucose | 4 | MOC |
| 12 | [ | |
| Pinosylvin | Glucose | 3 | MOC |
| 70 | [ | |
| Methylated Resveratrol derivatives | Glucose | 5 | MOC |
| NE | [ | |
| Mix of 3 glucosylated Resveratrol derivatives | Glucose | 4 | MOC |
| 11.7 | [ | |
| Resveratrol | NA | NA | NA | Cell suspension | 2140 | [ | |
| Resveratrol | NA | NA | NA | Cell suspension in flasks | 6141 | [ |